Insight into motor fatigue mechanisms in natalizumab treated multiple sclerosis patients with wearing off
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Insight into motor fatigue mechanisms in natalizumab treated multiple sclerosis patients with wearing off ; volume:14 ; number:1 ; day:26 ; month:7 ; year:2024 ; pages:1-10 ; date:12.2024
Scientific reports ; 14, Heft 1 (26.7.2024), 1-10, 12.2024
- Creator
-
Leodori, Giorgio
Mancuso, Marco
Maccarrone, Davide
Tartaglia, Matteo
Ianniello, Antonio
Certo, Francesco
Ferrazzano, Gina
Malimpensa, Leonardo
Belvisi, Daniele
Pozzilli, Carlo
Berardelli, Alfredo
Conte, Antonella
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-68322-w
- URN
-
urn:nbn:de:101:1-2410250841087.533795752768
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Leodori, Giorgio
- Mancuso, Marco
- Maccarrone, Davide
- Tartaglia, Matteo
- Ianniello, Antonio
- Certo, Francesco
- Ferrazzano, Gina
- Malimpensa, Leonardo
- Belvisi, Daniele
- Pozzilli, Carlo
- Berardelli, Alfredo
- Conte, Antonella
- SpringerLink (Online service)
Other Objects (12)
Natalizumab May Improve Cognition and Mood in Multiple Sclerosis
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Fatigue Management in Multiple Sclerosis
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Insight into metabolic 1H-MRS changes in natalizumab induced progressive multifocal leukoencephalopathy brain lesions
Gillian Wearing
Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials
GP6 rs2304166 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod
Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
Natalizumab May Improve Cognition and Mood in Multiple Sclerosis
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Fatigue Management in Multiple Sclerosis
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Insight into metabolic 1H-MRS changes in natalizumab induced progressive multifocal leukoencephalopathy brain lesions
Gillian Wearing
Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials
GP6 rs2304166 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod
Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
Natalizumab May Improve Cognition and Mood in Multiple Sclerosis
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Fatigue Management in Multiple Sclerosis
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Insight into metabolic 1H-MRS changes in natalizumab induced progressive multifocal leukoencephalopathy brain lesions
Gillian Wearing
Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials
GP6 rs2304166 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod